Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Hikal Ltd

NSE: HIKAL · BSE: 524735 · Pharmaceuticals & Biotechnology · 28 announcements

Share price
₹224.24
Market cap
₹2,765 Cr
Revenue (annual)
₹1,713 Cr
Net profit (annual)
₹-48.80 Cr
P/E (TTM)
-81.8×Sector 47.4×
Promoter holding
68.85%+0.00% QoQ
FII holding
0.98%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17:30 IST BSE
Board Meeting Date

Hikal Board Meeting Date

Hikal Ltd. scheduled a board meeting for August 06, 2026, to consider and approve standalone and consolidated unaudited financial results for the June quarter.

16:40 IST BSE
Board Meeting Date

Hikal Board Meeting Date

Hikal Ltd scheduled a Board Meeting on May 27, 2026, to approve audited FY26 financial results. The board will also consider recommending a final dividend.